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ABSTRACT
Objective No recent large studies have described the 
distribution of vitamin D status in the UK. Understanding 
the epidemiology of vitamin D deficiency is important to 
inform targeted public health recommendations. This study 
aimed to investigate the distribution of factors associated 
with serum vitamin D status in a large national cohort.
Design A cross- sectional study.
Setting The UK Biobank, a prospective cohort study 
following the health and well- being of middle- aged and 
older adults recruited between 2006 and 2010.
Participants A total of 449 943 participants aged 
40–69 years with measured serum vitamin D status 
were eligible for the analysis. Participants completed a 
questionnaire about sex, age, ethnic background, vitamin 
D supplementation, smoking, drinking and socioeconomic 
status.
Primary and secondary outcome measures We 
investigated the distribution of serum vitamin D status and 
the association between demographic factors and vitamin 
D deficiency or insufficiency. Vitamin D deficiency was 
defined as a serum 25- hydroxyvitamin D level <25 nmol/L. 
Multivariable logistic regression was used to assess the 
association between demographic factors and vitamin D 
status.
Results Asian (n=4297/8000, 53.7%) and black 
(n=2459/7046, 34.9%) participants had a higher 
proportion of vitamin D deficiency than white participants 
(n=50 920/422 907, 12%). During spring and winter, the 
proportion of vitamin D deficiency was higher across the 
UK and higher in the north than in the south. Male sex, 
abnormal body mass index, non- white ethnic backgrounds, 
smoking and being more socioeconomically deprived 
were associated with higher odds of vitamin D deficiency. 
Increasing age, taking vitamin D supplements and drinking 
alcohol were associated with lower odds of deficiency.
Conclusions Vitamin D status varied among different 
ethnic groups and by season and geographical area within 
the UK. Taking supplements was associated with a lower 
risk of vitamin D deficiency. These findings support the 
vitamin D supplementation recommendations of Public 
Health England.
INTRODUCTION
Vitamin D is essential to bone formation. 
It is mainly produced by the skin after sun 
exposure, and it can also be obtained from 
food and supplementation. After production 
or ingestion, it is further metabolised in the 
liver into 25- hydroxyvitamin D (25(OH)D), 
which can be measured in the blood. 25(OH)
D is further transformed in the kidneys into 
1,25- dihydroxyvitamin D, the active form of 
vitamin D. This active vitamin D metabolite 
acts on the intestines and kidneys, regulates 
the absorption and excretion of calcium and 
phosphate, and facilitates the mineralisation 
of bone. Vitamin D deficiency may impair 
bone mineralisation, leading to osteopenia 
or osteoporosis.1 Currently, Public Health 
England suggests that people older than 4 
years of age should take 10 μg (400 IU) of 
vitamin D daily as a supplement during the 
winter to support musculoskeletal health.2
In addition to the classical effects of mineral 
homeostasis, more recent attention has 
focused on novel effects of vitamin D. Previous 
studies have indicated that vitamin D may 
have potential immunomodulatory effects. 
Active vitamin D can enhance innate immu-
nity by increasing the production of antimi-
crobial peptides, and vitamin D can regulate 
adaptive immunity as well.3 Epidemiological 
studies have also indicated that vitamin D is 
associated with autoimmune diseases such as 
inflammatory bowel disease, type I diabetes 
mellitus and multiple sclerosis.4 In addition, 
Strengths and limitations of this study
 ► This study used a large cohort of British adults in 
middle and older age, and its large sample size 
provides more statistical power in assessing 
associations.
 ► The findings provide further evidence to support the 
nutritional supplementation recommendations of 
Public Health England.
 ► The cohort is not nationally representative, so the 
findings cannot be extrapolated to the general 
population.
 ► The questionnaire on vitamin supplementation was 
self- reported and thus cannot be used to estimate 
the required supplement amount.
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a meta- analysis using original data from trials suggested 
that taking vitamin D supplementation may decrease the 
risk of respiratory infections.5
Although 1,25- dihydroxyvitamin D plays an active role 
in metabolism, its half- life is less than 4 hours, while the 
half- life of 25(OH)D is around 2–3 weeks. Thus, clinical 
25(OH)D levels in the blood have been used to assess 
vitamin D status.6 25(OH)D can be analysed using either 
chemiluminescence immunoassay or tandem mass spec-
trometry, which are both recognised by the Royal Oste-
oporosis Society and Public Health England.6 7 However, 
no current consensus exists about the definition of 
vitamin D deficiency, so each study may use different stan-
dards. The Endocrine Society of the USA defined vitamin 
D deficiency as 25(OH)D below 50 nmol/L, while the 
criterion of Public Health England is 25(OH)D less than 
25 nmol/L.
Using the criterion of a blood vitamin D level less than 
25 nmol/L, a cohort of British Caucasians (n=7437) indi-
cated that in winter and spring, the average prevalence of 
vitamin D deficiency was 15.5% among people who were 
45 years old.8 Similarly, among adults in the National 
Diet and Nutrition Survey in the UK (n=3450), the prev-
alence of vitamin D deficiency was approximately 24.0% 
in men and 21.7% in women aged between 19 and 64 
years.9 However, these studies were relatively small, and 
no recent large study has described the distribution of 
vitamin D status in the UK.
The UK Biobank is a prospective, nationwide cohort 
used to investigate risk factors for major diseases in 
middle and old age; cohort participants were assessed 
for various biochemical biomarkers, including serum 
vitamin D status.10 11 By using UK Biobank data, we aimed 
to conduct a cross- sectional study to investigate different 
demographic, seasonal and regional factors associated 
with vitamin D deficiency distribution in the UK.
METHODS
Study population
The UK Biobank was compiled from 2006 to 2010 by 
recruiting participants throughout the UK. People aged 
40–69 years who lived within 40 km of 1 of the 22 UK 
Biobank assessment centres and who were registered 
with the UK National Health Service were eligible to be 
included in the cohort; approximately 500 000 volunteers 
were recruited.10 12 UK Biobank participants received a 
wide range of examinations, including questionnaires 
and physical measures, and blood, urine and saliva 
samples were assayed.6 Only participants with results for 
serum vitamin D status were included in our analyses.
Measurement of covariates
At each participant’s first visit to a UK Biobank assess-
ment centre, a touchscreen questionnaire collected basic 
demographic characteristics; sociodemographic, environ-
mental and lifestyle factors; and the date of assessment.10 
Information such as sex, age, ethnic background, skin 
Table 1 Comparison of included and excluded participants
Characteristics Included (N=449 943) Excluded (N=52 550)
Sex
  Female 240 976 (53.6%) 32 402 (61.7%)
  Male 208 967 (46.4%) 20 148 (38.3%)
Average age (SD) 56.5 (8.1) 57.0 (7.8)
BMI*
  Underweight 2307 (0.5%) 321 (0.6%)
  Healthy weight 145 082 (32.3%) 15 222 (29.7%)
  Overweight 190 177 (42.4%) 22 053 (43.1%)
  Obese 110 541 (24.7%) 13 600 (26.6%)
Central obesity*
  Not obese 177 869 (39.6%) 17 719 (34.5%)
  Central obesity 271 126 (60.4%) 33 642 (65.5%)
Ethnic background
  White 424 213 (94.4%) 47 901 (91.3%)
  Mixed 2593 (0.6%) 316 (0.6%)
  Asian 8016 (1.8%) 1823 (3.5%)
  Black 7050 (1.6%) 984 (1.9%)
  Chinese 1407 (0.3%) 167 (0.3%)
  Other ethnicity† 6068 (1.4%) 1267 (2.4%)
Tobacco smoking
  Non- smoker 402 337 (89.6%) 45 860 (88.3%)
  Current smoker 46 793 (10.4%) 6184 (11.9%)
Alcohol drinking status
  Never drink 35 590 (7.9%) 5071 (9.8%)
  Drink occasionally 101 690 (22.7%) 12 208 (23.5%)
  Drink weekly 220 709 (49.2%) 24 028 (46.2%)
  Drink daily 90 984 (20.3%) 10 713 (20.6%)
Vitamin and mineral 
supplementation use
  Vitamin D and 
associated mineral 
supplement‡
285 524 (63.6%) 31 097 (63.9%)
  Other vitamin 
and mineral 
supplement§
163 214 (36.4%) 17 537 (36.1%)
  Mean outdoor time 
in summer (SD)
3.8 (2.4) 3.8 (2.4)
  Mean outdoor time 
in winter (SD)
1.9 (1.8) 1.9 (1.8)
Index of Multiple 
Deprivation (IMD)¶
  1 (Least deprived) 88 516 (20.2%) 9616 (18.7%)
  2 88 210 (20.1%) 9782 (19.1%)
  3 87 584 (20.0%) 10 249 (20.0%)
  4 87 585 (20%) 10 306 (21.0%)
  5 (most deprived) 86 539 (19.7%) 11 370 (22.2%)
*The classification is suggested by NICE guidelines.
†Includes any other unlisted ethnic groups, unclear ethnic groups and 
participants prefer not to answer.
‡Vitamin D and associated mineral: vitamin D, multivitamin, fish oil and calcium 
supplementation.
§Other vitamin and mineral supplements: vitamin A, B, C, E, folic acid or folate, 
glucosamine, zinc, iron, selenium and other supplements.
¶IMD scores were by quintile.
BMI, body mass index; NICE, National Institute for Health and Care Excellence.
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Serum vitamin D levels (SD) (nmol/L) 19.2 (3.9) 37.8 (7.1) 67.7 (14.5)
Sex
  Female (N=240 263) 32 180 (13.4%) 100 423 (41.8%) 107 660 (44.8%)
  Male (N=208 338) 28 507 (13.7%) 87 368 (41.9%) 92 463 (44.4%)
Age (SD) 54.8 (8.2) 56.2 (8.1) 57.3 (8.0)
BMI*
  Underweight (N=2301) 423 (18.3%) 844 (36.7%) 1034 (45%)
  Healthy weight (N=144 591) 15 886 (11.0%) 54 115 (37.4%) 74 590 (51.6%)
  Overweight (N=189 583) 22 841 (12.1%) 79 351 (41.9%) 87 391 (46.1%)
  Obese (N=110 292) 20 990 (19.0%) 52 704 (47.8%) 36 598 (33.2%)
Central obesity*
  Non- obese (N=177 348) 19 514 (11.0%) 66 998 (37.8%) 90 836 (51.2%)
  Central obesity (N=270 306) 40 903 (15.1%) 120 389 (44.5%) 109 014 (40.3%)
Ethnic background
  White (N=422 907) 50 920 (12.0%) 176 195 (41.7%) 195 792 (46.3%)
  Mixed (N=2589) 642 (24.8%) 1241 (47.9%) 706 (27.3%)
  Asian (N=8000) 4297 (53.7%) 2979 (37.3 %) 724 (9.1%)
  Black (N=7046) 2459 (34.9%) 3503 (49.7%) 1084 (15.4%)
  Chinese (N=1405) 381 (27.1%) 787 (56.0%) 237 (16.9%)
  Other ethnicity† (N=6059) 1860 (30.7%) 2816 (46.5%) 1383 (22.8%)
Tobacco smoking
  Non- smoker (N=401 069) 50 270 (12.5%) 167 496 (41.8%) 183 303 (45.7%)
  Current smoker (N=46 721) 10 170 (21.7%) 19 944 (42.7%) 16 607 (35.6%)
Alcohol drinking status
  Never drink (N=35 503) 8419 (23.7%) 15 265 (43.0%) 11 819 (33.3%)
  Drink occasionally (N=101 398) 16 655 (16.4%) 45 208 (44.6%) 39 535 (39.0%)
  Drink weekly (N=219 988) 24 577 (11.1%) 90 836 (41.3%) 104 575 (47.6%)
  Drink daily (N=90 742) 10 730 (11.8%) 36 063 (39.7%) 43 949 (48.4%)
Mean outdoor time in summer (hours) (SD) 3.3 (2.4) 3.6 (2.4) 4.1 (2.4)
Mean outdoor time in winter (hours) (SD) 1.7 (1.8) 1.9 (1.8) 2.1 (1.8)
Vitamin and mineral supplementation use
  Other vitamin or mineral supplement‡ (N=284 
768)
48 877 (17.1%) 128 478 (45.1%) 107 413 (37.7%)
  Vitamin D and associated mineral 
supplement§ (N=162 629)
11 368 (7.0%) 58 801 (36.2%) 92 460 (56.9%)
Index of Multiple Deprivation (IMD)¶
  1 (least deprived, N=88 264) 8414 (9.5%) 34 962 (39.6%) 44 888 (50.9%)
  2 (N=87 909) 9321 (10.6%) 36 073 (41.0%) 42 515 (48.4%)
  3 (N=87 268) 10 480 (12.0%) 36 049 (41.3%) 40 739 (46.7%)
  4 (N=87 321) 13 211 (15.1%) 37 646 (43.1%) 36 464 (41.8%)
  5 (most deprived, N=86 347) 17 602 (20.4%) 38 369 (44.4%) 30 376 (35.2%)
Seasons
  Spring (N=129 570) 25 912 (20%) 62 378 (48.1%) 41 280 (31.7%)
  Summer (N=118 924) 5385 (4.5%) 39 856 (33.5%) 73 683 (62.0%)
  Autumn (N=108 888) 8324 (7.6%) 41 496 (38.1%) 59 068 (54.3%)
  Winter (N=91 219) 21 066 (23.1%) 44 061 (48.3%) 26 092 (28.6%)
Continued
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colour, smoking status, drinking status, sun exposure, 
and vitamin and mineral supplement use were recorded. 
Physical measurements, including body mass index (BMI) 
and waist circumference were also taken. The Index of 
Multiple Deprivation (IMD) of participants was obtained 
through data linkage.13
Defining serum vitamin D status
Biochemical assays were performed on blood samples 
collected during the baseline evaluation at the assessment 
centres.6 Briefly, serum samples were collected in a silica 
clot accelerator tube and stored at −80°C. These samples 
were later processed in a central laboratory using an auto-
mated dispensing system.14 Serum 25(OH)D status was 
measured by chemiluminescence immunoassay (DiaSorin 
LIAISON XL, Italy), which was certified by the Vitamin 
D Standardization- Certification Program of the Centers 
for Disease Control and Prevention.15 To ensure the 
precision of analysis, quality control samples at different 
concentrations were analysed,16 and the testing assay for 
vitamin D was verified through the RIQAS Immunoassay 
Speciality I EQA programme (Randox Laboratories), an 
external quality assurance scheme.17
Statistical analysis
This was a cross- sectional study describing the distribution 
of serum vitamin D status, so only participants who had 
at least one available measurement of serum vitamin D 
status were included. We used the standards of vitamin D 
deficiency adopted by Public Health England.6 18 A serum 
25(OH)D level less than 25 nmol/L was coded as ‘defi-
ciency’, and 25–50 nmol/L was coded as ‘insufficiency’. 
A 25(OH)D level greater than 50 nmol/L was coded as 
‘sufficiency’. Vitamin D was coded as missing in cases of 
no reportable value, values above or below the reportable 
limits, or unrecoverable aliquot problems.
To compare the distribution of vitamin D status by 
these factors associated with vitamin D, continuous 
covariates, such as BMI and waist circumference, were 
coded as categorical variables following National Institute 
for Health and Care Excellence guidelines.19 According 
to the guidelines, different BMI and waist circumference 
standards were applied for Asian and Chinese popu-
lations. Self- reported ethnic backgrounds were coded 
into six groups according to the original questionnaire. 
Participants with any other unlisted ethnic group, with 
an unclear ethnic group or preferring not to answer 
were assigned ‘other ethnic group’. The mean outdoor 
time was recorded as 0.5 hours/day if it was less than 1 
hour. Responses regarding vitamin and mineral use were 
further regrouped as ‘vitamin D, multivitamin, fish oil 
and calcium use’ and ‘other vitamin and mineral use’. 
IMD scores were categorised into five quintiles, with the 
fifth quintile assigned the ‘most deprived’ group. The 
locations of 22 Biobank assessment centres were grouped 
using the geographical regions of the UK.20 The date 
of blood collection for vitamin D examination was cate-
gorised into four seasons, according to the Met Office 
definitions.21
Demographic factors including sex, age (modelled as a 
continuous variable), ethnicity, BMI, smoking, drinking 
alcohol, IMD, vitamin D testing season and geographical 
location were further analysed in terms of their associ-
ation with vitamin D insufficiency (<50 nmol/L) and 








Regions of UK Biobank assessment centres
  South West (N=38 872) 3068 (7.9%) 14 622 (37.6%) 21 182 (54.5%)
  South East (N=39 814) 3245 (8.2%) 15 400 (38.7%) 21 169 (53.2%)
  London (N=61 291) 10 232 (16.7%) 27 037 (44.1%) 24 022 (39.2%)
  East Midlands (N=30 337) 3001 (9.9%) 12 115 (39.9%) 15 221 (50.2%)
  West Midlands (N=40 044) 6785 (17.0%) 17 670 (44.1%) 15 589 (38.9%)
  Wales (N=19 142) 2732 (14.3%) 8808 (46.0%) 7614 (39.8%)
  Yorkshire and The Humber (N=66 197) 8372 (12.7%) 27 878 (42.1%) 29 947 (45.2%)
  North West (N=68 196) 8715 (12.8%) 27 924 (41.0%) 31 557 (46.3%)
  North East (N=52 277) 6919 (13.2%) 21 174 (40.5%) 24 184 (46.3%)
  Scotland (N=32 419) 7618 (23.5%) 15 163 (46.8%) 9638 (29.7%)
*The classification is suggested by NICE guidelines.
†Includes any other unlisted ethnic groups, unclear ethnic groups and participants prefer not to answer.
‡Vitamin D and associated mineral: vitamin D, multivitamin, fish oil and calcium supplementation.
§Other vitamin and mineral supplements: vitamin A, B, C, E, folic acid or folate, glucosamine, zinc, iron, selenium and other 
supplements.
¶IMD scores were by quintile.
BMI, body mass index; NICE, National Institute for Health and Care Excellence.
Table 2 Continued
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Table 3 The association between demographic characteristics and low vitamin D status
Characteristics
OR of vitamin D insufficiency
(25(OH)D <50 nmol/L)
OR of vitamin D deficiency
(25(OH)D <25 nmol/L)
Crude Adjusted* Crude Adjusted*
Sex
  Female 1 1 1 1
  Male 1.02 (1.0, 1.03) 0.91 (0.90, 0.93) 1.02 (1.01, 1.04) 0.91 (0.9, 0.93)
  Age (SD) 0.98 (0.97, 0.97) 0.98 (0.98, 0.98) 0.97 (0.96, 0.97) 0.98 (0.98, 0.98)
BMI
  Healthy weight 1 1 1 1
  Underweight 1.3 (1.20, 1.42) 1.26 (1.14, 1.38) 1.83 (1.64, 2.03) 1.71 (1.51, 1.93)
  Overweight 1.25 (1.23, 1.26) 1.24 (1.22, 1.25) 1.11 (1.09, 1.13) 1.04 (1.01, 1.06)
  Obese 2.15 (2.11, 2.18) 2.08 (2.04, 2.12) 1.91 (1.86, 1.95) 1.68 (1.64, 1.72)
Ethnic background
  White 1 1 1 1
  Mixed 2.30 (2.11, 2.51) 2.24 (2.03, 2.46) 2.42 (2.21. 2.64) 2.31 (2.09, 2.56)
  Asian 8.67 (8.02, 9.35) 8.54 (7.87, 9.27) 8.47 (8.10,8.86) 10.99 (10.39, 11.62)
  Black 4.74 (4.44, 5.06) 4.14 (3.85, 4.45) 3.93 (3.74, 4.13) 3.6 (3.39, 3.83)
  Chinese 4.25 (3.70, 4.89) 4.42 (3.81, 5.14) 2.72 (2.42, 3.06) 2.77 (2.42, 3.18)
  Other ethnicity 2.91 (2.74, 3.10) 2.73 (2.55, 2.93) 3.24 (3.07, 3.42) 3.11 (2.9, 3.33)
Tobacco smoking
  Non- smoker 1 1 1 1
  Current smoker 1.53 (1.50, 1.56) 1.43 (1.40, 1.46) 1.94 (1.90, 1.99) 1.82 (1.77, 1.87)
Alcohol drinking status
  Never drink 1 1 1 1
  Drink occasionally 0.78 (0.76, 0.8) 0.85 (0.84, 0.88) 0.63 (0.61, 0.65) 0.75 (0.73, 0.78)
  Drink weekly 0.55 (0.53, 0.56) 0.66 (0.64, 0.68) 0.40 (0.39, 0.42) 0.55 (0.53, 0.57)
  Drink daily 0.53 (0.52, 0.55) 0.70 (0.68, 0.72) 0.43 (0.42, 0.45) 0.66 (0.64, 0.69)
Vitamin and mineral supplementation
  Other vitamin and mineral supplement 1 1 1 1
  Vitamin D, multivitamin, fish oil and 
calcium supplement
0.46 (0.45, 0.47) 0.41 (0.41, 0.42) 0.36 (0.35, 0.37) 0.32 (0.31, 0.33)
Index of Multiple Deprivation (IMD)†
  1 (least deprived) 1 1 1 1
  2 1.11 (1.09, 1.13) 1.03 (1.01, 1.05) 1.12 (1.09,1.16) 1.02 (0.98, 1.05)
  3 1.18 (1.16, 1.2) 1.05 (1.03,1.07) 1.29 (1.26,1.33) 1.11 (1.07, 1.14)
  4 1.44 (1.42, 1.47) 1.17 (1.14,1.19) 1.69 (1.64,1.74) 1.27 (1.23, 1.31)
  5 (most deprived) 1.91 (1.87, 1.94) 1.34 (1.31,1.37) 2.43 (2.36, 2.50) 1.53 (1.48, 1.58)
Seasons
  Summer 1 1 1 1
  Spring 3.48 (3.42, 3.54) 3.86 (3.79, 3.93) 5.26 (5.1, 5.42) 6.43 (6.22, 6.65)
  Autumn 1.37 (1.35, 1.40) 1.43 (1.40, 1.45) 1.74 (1.68, 1.80) 1.89 (1.82, 1.96)
  Winter 4.06 (3.99, 4.14) 4.56 (4.47, 4.65) 6.31 (6.12, 6.51) 7.82 (7.55, 8.1)
Regions (categorised centres)
  South West 1 1 1 1
  South East 1.05 (1.03, 1.08) 1.15 (1.11, 1.18) 1.04 (0.98, 1.09) 1.11 (1.05, 1.18)
  London 1.86 (1.81, 1.91) 1.31 (1.28, 1.35) 2.34 (2.24, 2.44) 1.31 (1.25, 1.38)
  East Midlands 1.19 (1.15, 1.23) 1.07 (1.04, 1.11) 1.28 (1.22, 1.35) 1.13 (1.07, 1.2)
  West Midlands 1.88 (1.82, 1.93) 1.22 (1.18, 1.26) 2.38 (2.27, 2.48) 1.26 (1.19, 1.32)
Continued
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logistic regression models. Covariates such as central 
obesity were not included in the model to avoid probable 
collinearity with BMI. All statistical analyses were carried 
out using Stata/MP V.15 (StataCorp, USA).
Patient and public involvement
Patients and/or the public were not involved in this retro-
spective study.
RESULTS
Comparison of included and excluded participants
We compared the included participants with those who 
did not have their vitamin D status tested (table 1). 
Vitamin D values were missing for 52 550 participants, 
who were excluded. Among excluded participants, the 
proportion of female participants (61.7%) was slightly 
higher than among the included participants (53.6%), 
while the distribution of the other categorical variables 
was similar across the included and excluded groups. 
The average age and mean outdoor time in summer were 
similar among included and excluded participants, while 
included participants who spent more time outside in 
winter.
Demographic distribution of vitamin D status
The demographic characteristics according to vitamin D 
status are shown in table 2. The average vitamin D levels 
were 19.2 nmol/L in the deficient group, 37.8 nmol/L in 
the insufficient group and 67.7 nmol/L in the sufficient 
group. The distribution of vitamin D status was similar in 
both sexes, and the mean age of the vitamin D sufficiency 
group was older than other groups. The proportion of 
vitamin deficiency was lower among people with healthy 
weight (n=15 886, 11%) and non- obese people (n=177 
348, 11%). Asian (n=4297, 53.7%) and black (n=2459, 
34.9%) people had a higher proportion of vitamin D defi-
ciency than white participants (n=50 920, 12.0%). Vitamin 
D deficiency was more prevalent among current smokers 
(n=10 170, 21.7%) and those who never drank alcohol 
(n=8419, 23.7%). People deficient in vitamin D spent less 
outdoor time in winter (mean=1.7 hours). The proportion 
of vitamin D deficiency was lower among participants 
taking vitamin D and associated mineral supplements 
(n=11 368, 7%) compared with people taking any other 
supplements (n=48 877, 17%). The most deprived people 
had the highest proportion of vitamin D deficiency (n=17 
602, 20.4%), while the least deprived participants had the 
lowest deficiency proportion (n=8414, 9.5%).
Vitamin D deficiency was more common in winter 
(n=21 066, 23.1%) and spring (25 912, 20%). Partici-
pants who visited assessment centres in Scotland had 
the highest proportion of vitamin D deficiency (n=7618, 
23.5%) compared with other assessment centres in the 
southern UK (table 2). A map showing the distribution 
of the proportion of vitamin D deficiency in different 
seasons by each UK Biobank assessment centre is illus-
trated in online supplemental figure 1. This shows that 
in winter and spring, vitamin D deficiency was prevalent 
across the country, while in summer and autumn it was 
less common. Furthermore, in spring, autumn and winter, 
the proportion of vitamin D deficiency in the northern 
part of the UK was higher than in the southern part of the 
country (online supplemental figure 1).
Association between demographic factors and vitamin D 
status
To assess the association of factors related to vitamin D 
status, the ORs of having vitamin D deficiency (25(OH)
D <25 nmol/L) or insufficiency (25(OH)D <50 nmol/L) 
were summarised in table 3. Male sex, abnormal BMI, 
smoking, non- white ethnicity, and being more deprived 
had greater odds of vitamin D deficiency or insufficiency. 
Increasing age, drinking alcohol, and taking vitamin D, 
multivitamin, fish oil or calcium supplements were asso-
ciated with lower odds of vitamin D deficiency or insuf-
ficiency. Compared with summer, receiving testing in 
spring or winter had greater odds of vitamin D deficiency 
or insufficiency. For the regions with assessment centres, 
Scotland had higher odds of vitamin D deficiency and 
insufficiency compared with other regions in the UK. 
After adjusting for the variables listed in table 3, these 
associations remained (table 3).
Characteristics
OR of vitamin D insufficiency
(25(OH)D <50 nmol/L)
OR of vitamin D deficiency
(25(OH)D <25 nmol/L)
Crude Adjusted* Crude Adjusted*
  Wales 1.81 (1.75, 1.88) 1.03 (0.99, 1.07) 1.94 (1.84, 2.05) 1.03 (0.97, 1.09)
  Yorkshire and The Humber 1.45 (1.41, 1.48) 1.19 (1.16, 1.23) 1.68 (1.61, 1.76) 1.30 (1.24, 1.36)
  North West 1.38 (1.35, 1.42) 1.15 (1.12, 1.18) 1.68 (1.61, 1.76) 1.28 (1.22, 1.34)
  North East 1.39 (1.35, 1.43) 1.23 (1.19, 1.27) 1.78 (1.7, 1.86) 1.53 (1.46, 1.61)
  Scotland 2.83 (2.74, 2.92) 1.98 (1.91, 2.05) 3.58 (3.43, 3.75) 2.39 (2.28, 2.51)
*Adjusted for sex, age, BMI categories, ethnicity, smoking, drinking, vitamin D supplementation, IMD, seasons, regions of UK Biobank 
assessment centres.
†IMD scores were by quintile.
BMI, body mass index; 25(OH)D, 25- hydroxyvitamin D.
Table 3 Continued
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DISCUSSION
In this cross- sectional study, we found that vitamin D 
deficiency was more prevalent among people of colour, 
in spring and winter, and in the northern UK. Male sex, 
abnormal BMI, non- white ethnic background, smoking 
and being more deprived increased the odds of vitamin 
D deficiency. Taking vitamin D supplements, drinking 
alcohol and increasing age were associated with decreased 
odds of vitamin D deficiency.
Our study showed that vitamin D status was strongly 
associated with seasonality and geographical distribution, 
which is similar to previous studies.8 9 Other studies have 
also indicated that vitamin D deficiency is more prevalent 
among non- white ethnic groups, such as south Asians. 
A small longitudinal study (n=140) in the UK showed 
that more than 90% of south Asian women in the cohort 
had vitamin D insufficiency (25(OH)D <50 nmol/L) 
throughout the year, while the proportion of insufficiency 
was much lower in the white comparison groups (20.3% 
in summer and 70% in winter).22 A systematic review of 
19 cross- sectional studies and 1 cohort study indicated 
that serum hydroxyvitamin D levels were lower among 
black, African American and non- Hispanic black groups, 
compared with Caucasian groups.23 These findings indi-
cate the importance of differences in ethnicity, latitude 
and season, which should always be considered in dietary 
guidelines and future nutritional studies of vitamin D.
We found that abnormal BMI, tobacco smoking, and 
deprivation increased the odds of vitamin D deficiency 
or insufficiency, while taking vitamin D and associated 
mineral supplements was associated with a lower risk of 
vitamin D deficiency or insufficiency. These results are 
consistent with other research about factors associated 
with vitamin D.1 24 25 The common vitamin D supplements 
contain around 400–2000 IU of vitamin D2 or D3, meeting 
the official daily intake guide. Our findings provide some 
evidence about the effect of vitamin D supplements as 
well as the Public Health England recommendation for 
vitamin D supplementation in winter and for some ethnic 
backgrounds.2
Curiously, age and drinking alcohol were inversely asso-
ciated with vitamin D status. Ageing has been regarded 
as a risk factor for vitamin D deficiency; however, our 
results showed that increasing age slightly decreased the 
odds of deficiency. Nevertheless, the mean age of our 
study population was 56.5 years, and age- related vitamin 
D deficiency tends to manifest at a more advanced age.26 
Another possible explanation is that our study population 
focused on middle- aged or older participants, who may be 
more likely to receive prescriptions containing vitamin D. 
However, this information was not included in our study. 
Regarding drinking alcohol, although a previous system-
atic review reported no consistent correlation between 
alcohol intake and serum vitamin D levels,27 recent 
studies have shown a negative association. A study using 
the National Health and Nutrition Examination Survey 
database in the USA from 2001 to 2010 showed the prev-
alence of vitamin D deficiency among current alcohol 
drinkers was 38% lower than in non- drinkers.25 Similarly, 
a cross- sectional survey in Portugal among 1500 partic-
ipants aged over 65 years showed that alcohol drinkers 
had lower odds of vitamin D deficiency compared with 
non- drinkers (moderate drinker: OR=0.49 (CI: 0.32 to 
0.73); excessive drinker: OR=0.48 (CI: 0.27 to 0.85)).24 
The mechanism behind this possible association is still 
unclear, and future studies about vitamin D should take 
alcohol into account.
The key strengths of our study are its large sample 
size and wide range of measurements, which provide 
more statistical power in analysing the factors associated 
with vitamin D deficiency. Moreover, information about 
the exposure and outcomes was collected following a 
predefined protocol, and samples were processed system-
atically, which minimises potential differential or non- 
differential misclassification bias. Our analysis about the 
association between demographic factors and vitamin 
D deficiency is solid. However, several important limita-
tions need to be considered. Despite the large size of the 
UK Biobank, this cohort is not nationally representative. 
Compared with non- participants, the participants of the 
UK Biobank were more likely to be older, women, and 
with a higher socioeconomic status and fewer health 
conditions.12 Due to this healthy volunteer effect, our 
findings on vitamin D status cannot be generalised to 
the UK population, and we may have underestimated 
the prevalence of vitamin D deficiency. Nevertheless, as 
the healthy volunteer effect does not affect the validity 
of exposure–outcome relationships, our findings on the 
factors associated with vitamin D status are likely to be 
valid.
This analysis has concentrated on vitamin D status using 
serum vitamin D levels obtained from a single blood test, 
which may not reflect long- term vitamin D status. Addi-
tionally, the questionnaires collecting information about 
vitamin D supplementation and outdoor physical activity 
could not precisely quantify the exposure. In further 
research, a more representative sample should be consid-
ered to assess the prevalence of vitamin D deficiency in the 
UK. Researchers may consider using repeated measure-
ments to assess long- term vitamin D status more precisely 
or including clinical diagnosis or vitamin D prescription 
to capture clinical status. In addition, collecting informa-
tion to quantify vitamin D supplementation and outdoor 
activities in different seasons can further validate the 
recommendation of Public Health England.
CONCLUSION
Vitamin D deficiency was more common in winter and 
spring, and its prevalence was higher in the northern UK 
than the southern UK. Male sex, abnormal BMI, Asian 
and black ethnic backgrounds, and tobacco smoking 
were associated with higher odds of vitamin D deficiency. 
Taking vitamin D supplements and drinking alcohol were 
associated with lower odds of vitamin D deficiency. These 
results provide some evidence supporting the Public 
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Health England recommendation for taking vitamin D 
supplementation in winter and for people with black or 
Asian ethnic backgrounds.
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